Close Menu

Rhinostics: Cheri Walker

Cheri Walker has been appointed president and CE of Rhinostics, a Cambridge, Massachusetts-based sample collection device firm. Walker has served in management roles at Invitrogen, Qiagen, Charles River Laboratories, Kailos Genetics, and most recently was senior VP of corporate development at Abcam. 


Waters: Sherry Buck, Michael Silveira

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.